Safety Study of Tezepelumab (AMG 157) in Healthy Adults

NCT00972179 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Placebo
DRUG: Tezepelumab

Sponsor

Amgen